Recently Viewed

News Announcement

Cipla: Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Dec-2021 Follow Value Research Online on Google download pdfDownload PDF Cipla

Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu® (Molnupiravir 200 mg) in India to treat mild to moderate COVID-19 at high risk of developing severe disease

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.